Uniphar plc (LON:UPR – Get Rating) shares were up 1.5% during trading on Thursday . The company traded as high as GBX 265 ($3.34) and last traded at GBX 265 ($3.34). Approximately 49,221 shares changed hands during trading, an increase of 202% from the average daily volume of 16,293 shares. The stock had previously closed at GBX 261 ($3.29).
Wall Street Analyst Weigh In
Separately, Shore Capital reissued a “buy” rating on shares of Uniphar in a report on Wednesday, March 22nd.
Uniphar Price Performance
The business has a 50 day moving average price of GBX 268.31 and a two-hundred day moving average price of GBX 282.26. The stock has a market cap of £723.50 million, a PE ratio of 1,766.67 and a beta of 0.76. The company has a debt-to-equity ratio of 97.55, a quick ratio of 0.60 and a current ratio of 0.99.
Uniphar Increases Dividend
Uniphar Company Profile
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers.
- Thinking Of Buying The Dip On JD.com? Consider This First
- Wynn Resorts: A Winning Bet for 2023
- A Royally Good Time To Buy The Walt Disney Company
- 3 Surprising Stocks Leading Growth Over Value
- Copa Holdings Is Looking For A Comeback, Its Dividend Agrees
Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.